Protective and Pathogenic Antibodies to Citrullinated Antigens
Immunological Reviews · 2026-09 · 342 (1)
DOI: 10.1111/imr.70165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 26.08.2026. Verfasst von Outi Sareila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Biophysics, Medical Inflammation Research, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoantibodies, Autoantigens, Anti-Citrullinated Protein Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Autoimmune diseases start years before clinical onset. In rheumatoid arthritis (RA), autoantibodies to citrullinated proteins (ACPA) and to modified IgG (rheumatoid factors, RF) can be detected many years before the inflammatory attack on cartilaginous joints. It has been assumed that these antibodies are pathogenic. We show here that many of the antibodies produced before disease onset are protective although there are likely also pathogenic clones directed to cartilaginous joints. To determine the function of these antibodies, it is crucial to analyze them in vivo, which is only possible in mouse models. To ease the translation, we have genetically humanized models which will now allow a more accurate analysis of autoimmune mechanisms in human disease. In this review, we will also discuss what we know today regarding the targeted epitopes and the role of pathogenic and protective antibodies. With this knowledge as the basis, we have developed new types of serologic tests for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Biophysics, Medical Inflammation Research, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Biochemistry and Microbiology, Medical Inflammation Research, Uppsala University, Uppsala, Sweden.
- National-Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Outi Sareila, Yibo He, Zhongwei Xu, Changrong Ge, Erik Lönnblom, Rikard Holmdahl
Förderung
- Vetenskapsrådet
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Sareila, O., He, Y., Xu, Z., Ge, C., Lönnblom, E., & Holmdahl, R. (2026). Protective and Pathogenic Antibodies to Citrullinated Antigens. Immunological Reviews, 342(1). https://doi.org/10.1111/imr.70165
Vancouver
Sareila O, He Y, Xu Z, Ge C, Lönnblom E, Holmdahl R. Protective and Pathogenic Antibodies to Citrullinated Antigens. Immunological Reviews. 2026;342(1). doi:10.1111/imr.70165
BibTeX
@article{Sareila2026,
author = {Sareila, Outi and He, Yibo and Xu, Zhongwei and Ge, Changrong and Lönnblom, Erik and Holmdahl, Rikard},
title = {Protective and Pathogenic Antibodies to Citrullinated Antigens},
journal = {Immunological Reviews},
year = {2026},
volume = {342},
number = {1},
doi = {10.1111/imr.70165}
}
EUVIMED